WASHINGTON (MedPage Today) — Congress may be out of town, but Washington came alive this week when a federal judge put a hold on NIH funding for embryonic stem cell research.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A joint warning from the FDA and CDC cautioned against reusing fingerstick and point-of-care (POC) blood testing devices because of the potential for transmission of bloodborne illnesses.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Food and Drug Administration turned down a request for accelerated approval of Roche-Genentech’s trastuzumab-DM1 for treatment of HER2-positive breast cancer.
No Comments »
Filed under: General Health News
(MedPage Today) — Forget tar and nicotine — the FDA is proposing to list as harmful or potentially harmful more than 100 chemicals found in tobacco and tobacco smoke, paving the way for tighter regulation of commercial tobacco products.
No Comments »
Filed under: General Health News
(MedPage Today) — The maker of an artificial hip system issued a voluntary recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has issued a warning against yet another product marketed as an “all-natural sexual enhancement” dietary supplement — this one called TimeOut — that contains a potentially dangerous analogue of the prescription drug sildenafil, the active ingredient in Viagra.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A joint warning from the FDA and CDC cautioned against reusing fingerstick and point-of-care (POC) blood testing devices because of the potential for transmission of bloodborne illnesses.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — The maker of an artificial hip system issued a voluntary recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has issued a warning against yet another product marketed as an “all-natural sexual enhancement” dietary supplement — this one called TimeOut — that contains a potentially dangerous analogue of the prescription drug sildenafil, the active ingredient in Viagra.
No Comments »
Filed under: Pharmacy News
Novartis’ single pill combination of aliskiren and amlopidine - Tekamlo - has been approved by the Food and Drug Administration (FDA) for the treatment of hypertension. Data revealed that Tekamlo significantly reduced blood pressure compared to amlodipine or aliskiren (Tekturna) alone. The medication has been approved in tablet form…
No Comments »
Filed under: Pharmacy News
